During the past decade, Rheumazentrum Ruhrgebiet conducted 16 clinical trials. In the 10-year time frame, 16 clinical trials started and 15 clinical trials were completed, i.e. on average, 93.8% percent of trials that started reached the finish line to date. In the past 5 years, 8 clinical trials started and 6 clinical trials were completed. i.e. 75% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Rheumazentrum Ruhrgebiet" #1 sponsor was "Charite University, Berlin, Germany" with 9 trials, followed by "Amgen" with 4 trials sponsored, "Hoffmann-La Roche" with 4 trials sponsored, "Eli Lilly and Company" with 3 trials sponsored and "Janssen Research & Development, LLC" with 3 trials sponsored. Other sponsors include 10 different institutions and companies that sponsored additional 14 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Rheumazentrum Ruhrgebiet" #1 collaborator was "Bristol-Myers Squibb" with 2 trials as a collaborator, "Abbott" with 1 trials as a collaborator, "Centocor BV" with 1 trials as a collaborator, "Centocor Ortho Biotech Services, L.L.C." with 1 trials as a collaborator and "Hoffmann-La Roche" with 1 trials as a collaborator. Other collaborators include 0 different institutions and companies that were collaborators in the rest 10 trials.

According to Clinical.Site data, the most researched conditions in "Rheumazentrum Ruhrgebiet" are "Ankylosing Spondylitis" (9 trials), "Rheumatoid Arthritis" (7 trials), "Arthritis, Psoriatic" (5 trials), "Psoriatic Arthritis" (4 trials) and "Spondylitis, Ankylosing" (3 trials). Many other conditions were trialed in "Rheumazentrum Ruhrgebiet" in a lesser frequency.

Most popular intervention types in "Rheumazentrum Ruhrgebiet" are "Drug" (36 trials), "Other" (3 trials) and "Biological" (2 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (15 trials), "Guselkumab" (3 trials), "Tocilizumab" (3 trials), "Etanercept" (2 trials) and "Methotrexate" (2 trials). Other intervention names were less common.

The vast majority of trials in "Rheumazentrum Ruhrgebiet" are 38 trials for "All" genders.

Currently, there are NaN active trials in "Rheumazentrum Ruhrgebiet". undefined are not yet recruiting, 4 are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 22 completed trials in Rheumazentrum Ruhrgebiet, undefined suspended trials, and 3 terminated clinical trials to date.

Out of the total trials that were conducted in Rheumazentrum Ruhrgebiet, 0 "Phase 1" clinical trials were conducted, 14 "Phase 2" clinical trials and 18 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 5 trials, and there were also 1 trials that are defined as “Not Applicable".